Treatment of the overactive bladder with detrusitol
Golomb, J.
Harefuah 139(11-12): 467-470
2000
ISSN/ISBN: 0017-7768 PMID: 11341197 Document Number: 512595
Document emailed within 1 workday
Related Documents
Goto, M.; Kato, K.; Kondo, A.; Otani, T.; Takita, T.; Kobayashi, M. 1988: Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial Hinyokika Kiyo. Acta Urologica Japonica 34(3): 541-550Nowara, A.; Witek, A.; Wilk, K. 2007: Diagnostic and treatment of overactive bladder Ginekologia Polska 78(7): 549-553
Khaled, S.M.; Elhilali, M. 2003: Role of 5-HT receptors in treatment of overactive bladder Drugs of Today 39(8): 599-607
Kupriyanov, Y.A.; Kasyan, G.R.; Pushkar, D.Y. 2018: A role of fesoterodine in treatment of overactive bladder Urologiia 6: 155-162
Maksimov, V.A.; Khodyreva, L.A.; Dudareva, A.A.; Al'bitskaia, A.I. 2011: Combined treatment of patients with prostatic adenoma and overactive bladder Urologiia 6: 46; 48-50
Akino, H. 2005: Pathophysiology and treatment of the overactive bladder syndrome in an aged male patient with voiding difficulty: pharmacological treatment Hinyokika Kiyo. Acta Urologica Japonica 51(9): 609-613
Soontrapa, S.; Ruksakul, W.; Nonthasood, B.; Tappayuthpijarn, P. 2003: The efficacy of Thai capsaicin in management of overactive bladder and hypersensitive bladder Journal of the Medical Association of Thailand 86(9): 861-867
Krhut, J.; Martan, A.; Zachoval, R.; Tvrdík, J.; Hanus, T. 2012: Current state of diagnostics and treatment of overactive bladder in the Czech Republic - five years ago and today Ceska Gynekologie 77(3): 205-210
Bunyavejchevin, S. 2005: Urinary symptoms and quality of life changes in Thai women with overactive bladder after tolterodine treatment Journal of the Medical Association of Thailand 88(11): 1497-1501
Merino Salas, S. 2018: Maintenance of the efficacy of the oxybutynin patch for the treatment of overactive bladder syndrome despite the change in the area of application: study of four cases Archivos Espanoles de Urologia 71(5): 502-505
Kul'chavenia, E.V.; Breusov, A.A.; Kholtobin, D.P. 2011: Overactive bladder as a cause of sexual dysfunction Urologiia 5: 87-89
Kubota, Y.; Sasaki, S.; Kojima, Y.; Hayase, M.; Kohri, K. 2007: Overactive bladder in female and new strategy Hinyokika Kiyo. Acta Urologica Japonica 53(6): 435-439
Nowara, A.; Witek, A.; Wilk, K. 2007: Overactive bladder--definition, epidemiology, pathogenesis Ginekologia Polska 78(6): 484-487
Prasopsanti, K.; Santi-Ngamkun, A.; Pornprasit, K. 2007: Estimated cost of overactive bladder in Thailand Journal of the Medical Association of Thailand 90(11): 2316-2320
Epstein, B.J.; Gums, J.G.; Molina, E. 2006: Newer agents for the management of overactive bladder American Family Physician 74(12): 2061-2068
Lajiness, M.J. 2010: Gelnique (oxybutynin chloride) 10% gel for overactive bladder Urologic Nursing 30(4): 253-254
Al'-Shukri, S.K.; Kuz'min, I.V. 2008: Assessment of symptoms severity in patients with overactive bladder Urologiia 6: 37-40
Kosier, J.H.; Combest, W.; Newton, M. 2006: Solifenacin succinate (VESIcare): overactive bladder therapy Urologic Nursing 26(6): 496-497
Patterson, A. 2011: Behaviour change to treat overactive bladder syndrome Nursing Times 107(46): 16; 18-19
Ogushi, T.; Takahashi, S. 2007: Effect of Chinese herbal medicine on overactive bladder Hinyokika Kiyo. Acta Urologica Japonica 53(12): 857-862